GREEN BAY, WI (April 16, 2012)—Enterogenic Intensive 100, a high-potency probiotic with 100 billion colony-forming units (CFU) per capsule, is now available to healthcare practitioners, exclusively through Integrative Therapeutics.
The launch of Enterogenic Intensive 100 has been much anticipated by Dr. Gaetano Morello, a naturopathic physician practicing in West Vancouver, Canada. "When my patients are experiencing digestive distress, I turn to probiotics to replenish the micro-flora of the intestines and deliver relief. I'm looking forward to recommending an affordable, high-potency option for my patients who need extra digestive support."
Enterogenic Intensive 100 features a broad spectrum of strains of Bifidobacteria and Lactobacilli that are resistant to both bile and stomach acid, combined with short-chain fructooligosaccharides (sc-FOS). An enteric-coated delivery system further protects the probiotics against the stomach's acid conditions, delivering a powerful dose of active organisms directly to the intestines.
Since the probiotic strains in Enterogenic Intensive 100 originate from human microflora, they are naturally compatible with the intestine's epithelial lining. In a double blind, randomized controlled trial, the probiotic species contained in this formulation have been shown to relieve occasional gas and constipation, bloating, and associated discomfort.*1-3
With 100 billion active CFU in each capsule, the formulation is one of the highest potency probiotics available. To order Enterogenic Intensive 100 for your patients, visit www.integrativeinc.com or call 800.931.1709.
Integrative Therapeutics, LLC manufactures and distributes proprietary, natural supplements exclusively to medical professionals. Our manufacturing facility meets stringent quality standards and is an organically certified and drug GMP audited facility. Find out more at www.integrativeinc.com.
- Drouault-Holowacz S, Bieuvelet S, Burckel A, et al. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome. Gastroenterol Clin Biol 2008;32:147–52.
- O'Mahony L, McCarthy J, Kelly P, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005;128:541–51.
- Rerksuppaphol S, Rerksuppaphol L. Lactobacillus acidophilus and Bifidobacterium bifidum stored at ambient temperature are effective in the treatment of acute diarrhoea. Ann Trop Paediatr 2010;30(4):299–304.
*This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.